AC IMMUNE SA Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
AC IMMUNE SA (ACIU) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of 4.79 CHF/shares as of 2024-12-31, per its 20-F filed 2025-03-13.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2025-03-13
- 2020-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 5.49 CHF.
- 2019-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 4.94 CHF.
- 2018-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 1.25 CHF.
- 2017-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 0.39 CHF.
CHF
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2020-12-31 | 5.49 CHF 20-F · filed 2021-03-23 |
| 2019-12-31 | 4.94 CHF 20-F · filed 2021-03-23 |
| 2018-12-31 | 1.25 CHF 20-F · filed 2021-03-23 |
| 2017-12-31 | 0.39 CHF 20-F · filed 2020-03-30 |
CHF/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2024-12-31 | 4.79 CHF/shares 20-F · filed 2025-03-13 |
| 2023-12-31 | 4.88 CHF/shares 20-F · filed 2025-03-13 |
| 2022-12-31 | 6.41 CHF/shares 20-F · filed 2025-03-13 |
| 2021-12-31 | 6.13 CHF/shares 20-F · filed 2024-03-14 |
| 2020-12-31 | 5.49 CHF/shares 20-F · filed 2023-03-16 |
| 2019-12-31 | 4.94 CHF/shares 20-F · filed 2022-03-22 |
| 2018-12-31 | 1.25 CHF/shares 20-F · filed 2021-03-23 |
| 2017-12-31 | 0.39 CHF/shares 20-F · filed 2020-03-30 |